Jeannette Gerspach

656 total citations
16 papers, 542 citations indexed

About

Jeannette Gerspach is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jeannette Gerspach has authored 16 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Jeannette Gerspach's work include Cell death mechanisms and regulation (7 papers), RNA Interference and Gene Delivery (7 papers) and Peptidase Inhibition and Analysis (5 papers). Jeannette Gerspach is often cited by papers focused on Cell death mechanisms and regulation (7 papers), RNA Interference and Gene Delivery (7 papers) and Peptidase Inhibition and Analysis (5 papers). Jeannette Gerspach collaborates with scholars based in Germany, United Kingdom and United States. Jeannette Gerspach's co-authors include Klaus Pfizenmaier, Harald Wajant, Sabine Münkel, Ingo Grunwald, Anja Krippner‐Heidenreich, B Schneider, Dafne Müller, Gisa Tiegs, Gabriele Sass and Júlia Németh and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Oncogene.

In The Last Decade

Jeannette Gerspach

16 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeannette Gerspach Germany 14 353 217 168 94 93 16 542
Jeomil Bae South Korea 11 390 1.1× 143 0.7× 167 1.0× 112 1.2× 119 1.3× 16 647
Stéphane Birklé France 17 651 1.8× 364 1.7× 218 1.3× 152 1.6× 94 1.0× 26 918
Natália Rodrigues Mantuano Switzerland 11 588 1.7× 349 1.6× 187 1.1× 88 0.9× 104 1.1× 17 795
Jianhua Chen China 15 376 1.1× 81 0.4× 132 0.8× 43 0.5× 116 1.2× 33 630
Sara Jacob Canada 9 408 1.2× 106 0.5× 196 1.2× 79 0.8× 40 0.4× 10 704
Martin Siegemund Germany 9 228 0.6× 137 0.6× 98 0.6× 76 0.8× 35 0.4× 14 387
Jörg Volkland Germany 8 464 1.3× 244 1.1× 335 2.0× 133 1.4× 78 0.8× 9 710
Tamara Lah Turnšek Slovenia 15 352 1.0× 165 0.8× 210 1.3× 33 0.4× 202 2.2× 32 705
Tim Kees Germany 8 283 0.8× 391 1.8× 305 1.8× 23 0.2× 113 1.2× 8 781
Steffi Lehmann Switzerland 8 203 0.6× 104 0.5× 222 1.3× 60 0.6× 136 1.5× 14 555

Countries citing papers authored by Jeannette Gerspach

Since Specialization
Citations

This map shows the geographic impact of Jeannette Gerspach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeannette Gerspach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeannette Gerspach more than expected).

Fields of papers citing papers by Jeannette Gerspach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeannette Gerspach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeannette Gerspach. The network helps show where Jeannette Gerspach may publish in the future.

Co-authorship network of co-authors of Jeannette Gerspach

This figure shows the co-authorship network connecting the top 25 collaborators of Jeannette Gerspach. A scholar is included among the top collaborators of Jeannette Gerspach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeannette Gerspach. Jeannette Gerspach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wajant, Harald, Jeannette Gerspach, & Klaus Pfizenmaier. (2011). Engineering death receptor ligands for cancer therapy. Cancer Letters. 332(2). 163–174. 56 indexed citations
2.
Gerspach, Jeannette, Klaus Pfizenmaier, & Harald Wajant. (2011). Therapeutic Targeting of CD95 and the TRAIL Death Receptors. Recent Patents on Anti-Cancer Drug Discovery. 6(3). 294–310. 20 indexed citations
3.
Gerspach, Jeannette, et al.. (2010). Genetic Engineering of Death Ligands for Improvement of Therapeutic Activity. Advances in experimental medicine and biology. 691. 507–519. 1 indexed citations
4.
Schneider, B, Sabine Münkel, Anja Krippner‐Heidenreich, et al.. (2010). Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins. Cell Death and Disease. 1(8). e68–e68. 59 indexed citations
5.
Gerspach, Jeannette, Klaus Pfizenmaier, & Harald Wajant. (2009). Improving TNF as a cancer therapeutic: Tailor‐made TNF fusion proteins with conserved antitumor activity and reduced systemic side effects. BioFactors. 35(4). 364–372. 15 indexed citations
6.
Gerspach, Jeannette, Harald Wajant, & Klaus Pfizenmaier. (2009). Death Ligands Designed to Kill: Development and Application of Targeted Cancer Therapeutics Based on Proapoptotic TNF Family Ligands. Results and problems in cell differentiation. 49. 241–273. 9 indexed citations
7.
Krippner‐Heidenreich, Anja, Ingo Grunwald, Gudrun Zimmermann, et al.. (2008). Single-Chain TNF, a TNF Derivative with Enhanced Stability and Antitumoral Activity. The Journal of Immunology. 180(12). 8176–8183. 53 indexed citations
8.
Gerspach, Jeannette, et al.. (2006). Activation of CD95L fusion protein prodrugs by tumor-associated proteases. Cell Death and Differentiation. 14(4). 765–774. 31 indexed citations
9.
Gerspach, Jeannette, Júlia Németh, Sabine Münkel, Harald Wajant, & Klaus Pfizenmaier. (2006). Target-selective activation of a TNF prodrug by urokinase-type plasminogen activator (uPA) mediated proteolytic processing at the cell surface. Cancer Immunology Immunotherapy. 55(12). 1590–1600. 23 indexed citations
10.
Wajant, Harald, Jeannette Gerspach, & Klaus Pfizenmaier. (2005). Tumor therapeutics by design: targeting and activation of death receptors. Cytokine & Growth Factor Reviews. 16(1). 55–76. 101 indexed citations
11.
Gerspach, Jeannette, Dafne Müller, Sabine Münkel, et al.. (2005). Restoration of membrane TNF-like activity by cell surface targeting and matrix metalloproteinase-mediated processing of a TNF prodrug. Cell Death and Differentiation. 13(2). 273–284. 37 indexed citations
12.
Schlett, Katalin, Friedrich Metzger, Frank Steigerwald, et al.. (2004). Long-term NR2B expression in the cerebellum alters granule cell development and leads to NR2A down-regulation and motor deficits. Molecular and Cellular Neuroscience. 27(3). 215–226. 14 indexed citations
13.
Müller, Dafne, Jeannette Gerspach, Gabriele Sass, et al.. (2003). Generation of a FasL-based Proapoptotic Fusion Protein Devoid of Systemic Toxicity due to Cell-surface Antigen-restricted Activation. Journal of Biological Chemistry. 278(34). 32077–32082. 60 indexed citations
14.
Wüest, Thomas, et al.. (2002). TNF-Selectokine: a novel prodrug generated for tumor targeting and site-specific activation of tumor necrosis factor. Oncogene. 21(27). 4257–4265. 28 indexed citations
15.
Gerspach, Jeannette, et al.. (2000). Detection of membrane-bound tumor necrosis factor (TNF): An analysis of TNF-specific reagents. Microscopy Research and Technique. 50(3). 243–250. 19 indexed citations
16.
Klein, Matthias, et al.. (1999). Regulation of the murine NMDA‐receptor‐subunit NR2C promoter by Sp1 and fushi tarazu factor1 (FTZ‐F1) homologues. European Journal of Neuroscience. 11(6). 2083–2092. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeomil Bae Breakdown of academic impact, for papers by Stéphane Birklé Breakdown of academic impact, for papers by Natália Rodrigues Mantuano Breakdown of academic impact, for papers by Jianhua Chen Breakdown of academic impact, for papers by Sara Jacob Breakdown of academic impact, for papers by Martin Siegemund Breakdown of academic impact, for papers by Jörg Volkland Breakdown of academic impact, for papers by Tamara Lah Turnšek Breakdown of academic impact, for papers by Tim Kees Breakdown of academic impact, for papers by Steffi Lehmann
Rankless by CCL
2026